Checklists for Powder Inhaler Technique: A Review and Recommendations

Size: px
Start display at page:

Download "Checklists for Powder Inhaler Technique: A Review and Recommendations"

Transcription

1 Checklists for Powder Inhaler Technique: A Review and Recommendations Iman A Basheti PhD, Sinthia Z Bosnic-Anticevich PhD, Carol L Armour PhD, and Helen K Reddel PhD Introduction Review of the Literature Search Strategy Published Inhaler Technique Checklists and Reporting Systems Number and Categorization of Steps Scoring and Reporting Systems for Inhaler Technique Checklists Source of Information for Checklists Summary Evidence for Inclusion of Individual Technique Steps in Device Checklists Evidence for Additional Steps Essential Steps for the Turbuhaler and Diskus Reporting Turbuhaler/Diskus Technique Data Clinical Impact of Using Inhaler Technique Checklists Conclusions Turbuhaler and Diskus are commonly used powder inhaler devices for patients with respiratory disease. Their effectiveness is limited in part by a patient s ability to use them correctly. This has led to numerous studies being conducted over the last decade to assess the correct use of these devices by patients and health care professionals. These studies have generally used device-specific checklists to assess technique, this being the most feasible and accessible method for assessment. However, divergence between the checklists and scoring systems for the same device in different studies makes direct comparison of results difficult and at times inappropriate. Little evidence is available to assess the relative importance of different criteria; however, brief patient training based on specific inhaler technique checklists leads to significant improvement in asthma outcomes. This paper reviews common checklists and scoring systems used for Turbuhaler and Diskus, discusses the problem of heterogeneity between different checklists, and finally recommends suitable checklists and scoring systems for these devices based on the literature and previous findings. Only when similar checklists are used across different research studies will accurate comparisons and meta-analysis be possible. Key words: inhalers; checklists; technique; pharmacists; scoring systems. [Respir Care 2014;59(7): Daedalus Enterprises] Dr Basheti is affiliated with the Faculty of Pharmacy, Applied Science University, Amman, Jordan. Drs Bosnic-Anticevich, Armour, and Reddel are affiliated with the Woolcock Institute of Medical Research, University of Sydney, New South Wales, Australia. The authors have disclosed no conflicts of interest. Correspondence: Iman A Basheti PhD, Faculty of Pharmacy, Applied Science University, PO Box 166, Amman 11931, Jordan. dr_iman@asu.edu.jo. DOI: /respcare RESPIRATORY CARE JULY 2014 VOL 59 NO 7

2 Introduction Powder inhaler devices have been developed over the last 2 decades for treatment of asthma and COPD. These small portable devices contain micronised powdered medication, often with a carrier, with the particles dispersed during These devices were developed for use in adults and older children and have been shown to deliver drugs safely and effectively. 1,2 Several types of powder inhalers are available, some as single-dose, capsule-based inhalers, such as the Aerolizer (Novartis, Basel, Switzerland), or HandiHaler (Boehringer Ingelheim, Ingelheim, Germany). More commonly, powder inhalers are multidose inhalers, either reservoir-type inhalers, such as the Turbuhaler (AstraZeneca, London, United Kingdom) (similar to the Flexhaler), Clickhaler (Vectura, Wiltshire, United Kingdom), Easyhaler (Orion, Espoo, Finland), and Novolizer (Meda, Solna, Sweden), or based on prefilled blisters, such as the Diskus Accuhaler (GlaxoSmithKline, Brentford, England), or blister disks, such as the Diskhaler (GlaxoSmithKline, Brentford, England). The acceptance of powder inhalers has been driven in large part by the enormous success in recent years of combination treatment with a corticosteroid and a long-acting 2 agonist. 3 The combination of budesonide and formoterol fumarate dihydrate (Symbicort) in the Turbuhaler and fluticasone propionate and salmeterol xinafoate (Seretide) in the Diskus reflects current treatment guidelines for moderate to severe asthma and COPD. These devices have been found to be the most efficient and commonly used of the powder inhaler devices. 4,5 Many factors play a role in the overall performance of the Turbuhaler 6 (Fig. 1) and Diskus 7 (Fig. 2), from their pharmaceutical formulations to their mechanical and aerodynamic properties and to the way they are used by people with airway disease. Correct device use is critical to the delivery of medication to the airways. Many studies have been conducted to assess and improve the way people use the Turbuhaler and Diskus. Some studies have used specific devices for assessing individual components of inhaler technique. For example, devices such as the Turbutest measure the patient s inspiratory flow through a placebo Turbuhaler. 8,9 Portable devices for assessing some components of inhaler technique were recently reviewed. 10 One example is the Inhalation Manager, which measures inspiratory flow through inhalation devices (including a stylized powder inhaler) using a pneumotachometer; this system also predicts drug delivery mass and particle deposition based on in vitro data. 11 This instrument is proposed as a tool for assessing and training patients on correct inhaler technique and for identifying the most suitable inhaler for an individual patient, 11 but it is not feasible on a wide scale and requires technical support. The Turbuhaler whistle Fig. 1. Turbuhaler. Courtesy AstraZeneca. (AstraZeneca Pharmaceuticals) is a simple device that whistles if the patient inhales 35 L/s. 12 However, by far the most common, feasible, and accessible method of assessing inhaler technique is through the use of device-specific inhaler technique checklists. The validity of inhaler technique checklists was initially established by Appel, 13 who showed that trained personnel were able to achieve a 98% success rate in predicting the bronchodilator response for patients with asthma using their reliever devices by observing their inhaler technique. More recently, inhaler technique checklists have been shown to be feasible tools for assessment of technique. The clinical utility of inhaler checklists has been confirmed by studies with powder inhalers 14 and pressurized metered-dose inhalers, 15 which have shown that, when brief patient training was based on a standardized inhaler technique checklist, there were significant improvements in asthma outcomes. Hence, it can be concluded that assessment and correction of asthma patients inhaler technique against a checklist are valid measurements of the effectiveness of the inhalation devices in terms of delivering improved clinical outcomes. RESPIRATORY CARE JULY 2014 VOL 59 NO

3 Fig. 2. Diskus. Courtesy GlaxoSmithKline. A systematic review of the effectiveness of different inhaler devices in asthma and COPD noted problems in comparisons between studies because of variation in the relevant inhaler technique checklists. 16 The objective of the present review was therefore to describe and compare the inhaler technique checklists and scoring systems reported for Turbuhaler and Diskus and to recommend uniform checklists and scoring systems for use in future studies and in clinical practice. Search Strategy Review of the Literature The search strategy included PubMed, Embase, and International Pharmacy Abstracts up to Key words used for the search included inhaler technique, checklists, Turbuhaler, Turbohaler, Accuhaler, Diskus, and incorrect use. The titles and abstracts of all articles produced by this search were assessed for inclusion before retrieval of full articles. These articles were then subsequently reassessed for inclusion, and only those presenting checklists for the Turbuhaler and/or Diskus and meeting the inclusion criteria were included in the review. No blinding of authors names or institutions was done, and no scoring system for study quality was used. The inclusion criteria were studies of Turbuhaler or Diskus usage involving subjects with asthma or COPD and/or health care professionals. Only publications in the English language were included. Letters to editors, commentaries, cost analyses, and surveys were excluded. Instructions packaged with the inhaler devices themselves were also included. Published Inhaler Technique Checklists and Reporting Systems Twenty-six research articles were included in the analysis of inhaler technique checklists for the Turbuhaler and Diskus. Table 1 lists these checklists, together with the list of steps in the manufacturers instructions. Number and Categorization of Steps The 24 different checklists for the Turbuhaler and 16 for the Diskus. It shows substantial variation between checklists in the number of steps listed, ranging from 3 to 14 steps for the Turbuhaler and from 3 to 13 steps for the Diskus. Most checklists included removing the Turbuhaler cap (19/24) or opening the Diskus cover (14/16), and all checklists included steps for loading a dose and inhaling the dose. However, first exhaling away from the mouthpiece was listed in fewer than half of checklists for both devices. The speed of inhalation, most often described as needing to be strong and forceful, was not mentioned in 4 of 24 Turbuhaler checklists and in 3 of 16 Diskus checklists. Almost all checklists included breath-holding after inhalation (21 of 24 for the Turbuhaler and 13 of 16 for the 1142 RESPIRATORY CARE JULY 2014 VOL 59 NO 7

4 Table 1. Checklists Used in the Assessment of Inhaler Technique in Clinical Studies for the Turbuhaler and Diskus Authors/Manufacturer Turbuhaler Instructions Diskus Instructions Stated Sources Manufacturers instructions There are additional instructions for first use of Symbicort. (1) Unscrew and lift off the cover. (2) Hold your Turbuhaler upright with the red grip at the bottom. (3) Turn the red grip as far as it will go in one direction and then turn it as far as it will go in the other direction. You should hear a click sound. (4) Hold your Turbuhaler away from your mouth. Breathe out gently (as far as is comfortable). (5) Place the mouthpiece gently between your teeth. Close your lips. (6) Breathe in as deeply and as hard as you can through your mouth. (7) Remove your Turbuhaler from your mouth. (8) Breathe out gently. (9) If you are to take a second inhalation, repeat steps 2 6. (10) Replace the cover tightly after use. (11) Rinse your mouth with water after your daily morning and/or evening doses and spit it out. (1) Hold the Diskus in one hand and put the thumb of your other hand on the thumb grip. (2) Push your thumb away from you as far as it will go until the mouthpiece appears and snaps into position. (3) Hold the Diskus in a level horizontal position with the mouthpiece towards you. (4) Slide the lever away from you as far as it will go until it clicks. (5) Before inhaling your dose, breathe out as far as is comfortable, holding the Diskus level and away from your mouth. (6) Put the mouthpiece to your lips. Breathe in quickly and deeply through the Diskus, not through your nose. (7) Remove the Diskus from your mouth. Hold your breath for 10 s or for as long as is comfortable. (8) Breathe out slowly. (9) Close the Diskus when you are finished taking a dose so that the Diskus will be ready for you to take your next dose. (10) Put your thumb on the thumb grip and slide the thumb grip back towards you as far as it will go. The Diskus will click shut. The lever will automatically return to its original position. Manufacturers instructions for the Symbicort Turbuhaler* and Diskus Al-Doghim 17 (1) Remove Cap Checklist based on (2) Hold the inhaler upright, turn the grip to the right as far as it will go. and turn the grip back again to the left until it clicks. (3) Exhale slowly. (4) Place the mouthpiece between your teeth and lips. (5) Inhale forcefully and deeply. (6) Remove the inhaler from your mouth before breathing out. previous studies Basheti et al 14 (1) Remove the cap from the inhaler. (1) Open the inhaler. Checklist based on (2) Keep the inhaler upright. (2) Push the lever back completely. previous study by van der Palen et al (3) Rotate the grip counterclockwise and (3) Exhale to RV. 18 then back until a click is heard. (4) Exhale away from mouthpiece. (4) Exhale to RV. (5) Exhale away from the mouthpiece. (5) Place the mouthpiece between teeth and lips. (6) Place the mouthpiece between teeth (6) Inhale forcefully and deeply. and lips. (7) Hold breath for 5 s. (7) Inhale forcefully and deeply. (8) Exhale away from the mouthpiece. (8) Hold breath for 5 s. (9) Close the inhaler. (9) Exhale away from the mouthpiece. Basheti et al 19 (1) Remove the cap from the inhaler. Checklist based on (2) Keep inhaler upright on a flat surface. (3) Rotate the grip counterclockwise and then back until a click is heard. (4) Exhale to RV. (5) Exhale away from the mouthpiece. (6) Place the mouthpiece between teeth and lips. (7) Inhale forcefully and deeply. (8) Hold breath for 5 s. (9) Exhale away from the mouthpiece. previous study by van der Palen et al 18 (continued) RESPIRATORY CARE JULY 2014 VOL 59 NO

5 Table 1. Continued Authors/Manufacturer Turbuhaler Instructions Diskus Instructions Stated Sources Cain et al 20 (1) Remove the cover. (1) Put your thumb on the thumb grip and push Manufacturers (2) Turn the bottom clockwise until it clicks while keeping the inhaler upright. the grip away from you as far as it will go until the mouthpiece appears and snaps into instructions (3) Turn the bottom counterclockwise to the maximum while keeping the inhaler upright. (4) Turn head away from the inhaler and exhale to FRC or RV. position. (2) Slide the lever away from you as far as it will go until it clicks while keeping the Diskus horizontal. (5) Place the mouthpiece between lips (3) Holding the Diskus horizontally and away horizontally or vertically and inhale deeply from your mouth, breathe out to FRC or RV. and forcefully. (6) Hold breath in full inspiration for 5 10 s (4) Put the mouthpiece to your lips and breath and exhale. in steadily and deeply. (5) Remove the Diskus from your mouth. Hold breath in full inspiration for 5 10 s and exhale. (6) Put your thumb on the grip and slide the thumb grip back towards you as far as it will go to click it shut. Chopra et al 21 (1) Remove the cover. (1) Put the thumb of your hand on the thumb Manufacturers (2) Turn the bottom clockwise until it clicks while keeping the inhaler upright. grip and push your thumb away from you as far as it will go until the mouthpiece appears instructions (3) Turn the bottom counterclockwise to the maximum while keeping the inhaler upright. (4) Turn your head away from the inhaler and exhale to FRC or RV. and snaps into position. (2) Slide the lever away from you as far as it will go until it clicks while keeping the Diskus horizontal. (5) Place the mouthpiece between your lips (3) Holding the Diskus horizontally and away horizontally or vertically and inhale deeply from your mouth, breathe out to FRC or RV. and forcefully. (6) Hold your breath in full inspiration for (4) Put the mouthpiece to your lips and breathe 5 10 s and exhale. in steadily and deeply. (5) Remove the Diskus from your mouth. Hold your breath in full inspiration for 5 10 s and exhale. (6) Put your thumb on the thumb grip and slide the thumb grip back towards you as far as it will go to click it shut. García-Cárdenas et al 22 (1) Unscrew and lift off the cover. Spanish guidelines for (2) Hold the inhaler upright. asthma management (3) Twist the red grip fully to the right as far as it will go and twist it back again to the left. A click will be heard. (4) Breathe out gently taking care not to breathe into the Turbuhaler. (5) Place the mouthpiece between teeth and lips. (6) Inhale forcefully and deeply. (7) Remove the inhaler from your mouth, hold breath for 8 s, and exhale away from the mouthpiece. (8) If further doses are needed, wait 30 s and repeat steps 2 7. (9) Replace white cap. (10) Rinse your mouth with water. Do not swallow. Epstein et al 23 (1) Remove the cover before the first puff. Manufacturers (2) Do not shake the inhaler. recommendations and based on (3) Hold the inhaler upright for priming. previous studies by (4) Turn the wheel correctly to the right. (5) Turn the wheel correctly to the left until Hanania et al 24 and Kesten et al 25 there is a click. (6) Breath out. (7) Breath away from the inhaler prior to (8) Put the mouthpiece between lips. (9) Breath in deeply. (10) Breath forcefully through your mouth. (11) Remove the inhaler from your mouth. (12) Hold breath for 5 s before exhaling. (14) Replace the cover after the second puff. (continued) 1144 RESPIRATORY CARE JULY 2014 VOL 59 NO 7

6 Table 1. Continued Authors/Manufacturer Turbuhaler Instructions Diskus Instructions Stated Sources Hanania et al 24 (1) Remove the cover. Not stated (2) Hold the inhaler upright. (justifications given) (3) Turn the bottom clockwise and then counterclockwise. (4) Exhale away from inhaler to FRC or RV. (5) Insert the mouthpiece between lips. (6) Breathe in forcefully and deeply. (7) Do not exhale. Remove the inhaler from your mouth. (8) Hold breath to comfort (5 10 s). (9) Exhale. Wait s before a second (10) Hold upright. (11) Rotate bottom again before a second Kamps et al 26 (1) Rotate the Turbuhaler counterclockwise and (1) Open the Diskus and push the handle back Netherlands Asthma back while keeping it upright. completely. Foundation (2) Place the mouthpiece between teeth and (2) Place the mouthpiece between teeth and lips. lips. (3) Inhale forcefully and deeply. (3) Inhale forcefully and deeply. Kesten et al 25 (1) Remove the cover. Not stated (2) Hold the inhaler upright. (justifications given) (3) Turn the bottom completely to the right and then left until a click is heard. (4) Exhale away from inhaler to FRC or RV. (5) Put the mouthpiece between lips. (6) Breathe in forcefully and deeply. (7) Do not exhale. Remove the inhaler from your mouth. (8) Hold breath according to comfort. (9) Exhale. Wait a minimum of s before second (10) Hold upright. (11) Rotate the bottom correctly. Khassawneh et al 27 (1) Unscrew and lift off the cover. (1) Open the device. Checklist derived (2) Hold the inhaler upright with the grip (2) Slide the lever until it clicks. from medication downwards. leaflet and previous (3) Breathe in rapidly and deeply. studies (3) Turn the grip until it clicks (4) Breathe in rapidly and deeply. Lareau and Hodder 31 Steps to prepare for inhalation after unscrewing/removing/opening the cap: (1) Twist the grip as far as possible in one direction. (2) Twist the grip back until it clicks. Other steps given as critical errors: Failure to remove cap Holding inhaler upside down Failure to load dose Blowing into device Failure to make tight seal with lips Inhalation too weak or too slow Lenney et al 29 (1) Remove the mouthpiece cover. (1) Rotate the cover to expose the mouthpiece. Not stated (2) Prime inhaler by twisting the base until it (2) Prime the device by pushing the lever back clicks with device vertical 45. until it pops. (3) Breathe out gently. (3) Continue as for the Turbuhaler. (4) Place the inhaler between lips and breathe in quickly and deeply until full. (5) Hold breath for 10 s. Checklist derived from instructions in package inserts and adapted from previous work 32 (justifications given) (continued) RESPIRATORY CARE JULY 2014 VOL 59 NO

7 Table 1. Continued Authors/Manufacturer Turbuhaler Instructions Diskus Instructions Stated Sources Melani et al 33 (1) Remove the cover. (1) Turn the cover. Checklist translated (2) Hold the inhaler upright. (2) Load the dose. from the original Italian format in a (3) Load the dose. (3) Inhale by mouth. supplementary data (4) Place the mouthpiece between lips. (4) Breathe out the device mouthpiece. file prepared by the (5) Inhale by mouth. (5) Inhale deeply and quickly. Educational Group members (6) Breathe out the device mouthpiece. (6) Place the mouthpiece between your lips. (7) Inhale deeply and quickly. (7) Inhale forcefully and deeply. (8) Breathe forcefully and deeply. (8) Hold breath. (9) Hold breath. (9) Breathe out the device mouthpiece. (10) Breathe out the device mouthpiece. Melani et al 34 (1) Remove the cap correctly. (1) Correctly remove the cap. Global Initiative for (2) Load successfully. (2) Load successfully. Asthma guidelines, Global Initiative for (3) Hold the device upright. (4) After loading, never exhale through the Chronic (4) After loading, never exhale through the mouthpiece. Obstructive Lung mouthpiece. (5) Exhale to RV before Disease Executive (5) Exhale to RV before (6) Place the mouthpiece into the mouth, Committee, and sealing the lips. manufacturers instructions (6) Place the mouthpiece into the mouth, sealing the lips. (7) Inhale forcefully. (7) Inhale forcefully. (8) Inhale by mouth and not by nose. (8) Inhale by mouth and not by nose. (9) Continue to inhale for as long as possible. (9) Continue to inhale for as long as possible. (10) Hold breath for 4 6 s/hold breath for (10) Hold breath for 4 6 s/hold breath for 8 10 s s. (11) Replace the mouthpiece cover. (11) Never exhale into the mouthpiece after (12) Replace the mouthpiece cover. Molimard et al 28 (1) Hold the inhaler upright (tolerance of (1) Hold the mouthpiece towards you. Manufacturers 45 ). (2) Slide the lever as far as possible. instructions (2) Rotate the grip and back until it clicks. (3) Exhale before (3) Exhale before (4) Exhale away from the mouthpiece. (4) Exhale away from the mouthpiece. (5) Inhale through the mouthpiece. (5) Inhale through the mouthpiece. (6) Hold breath a few seconds. (6) Hold breath a few seconds. Moore and Stone 35 (1) Correctly remove the cap. (1) Correctly remove the cap Not stated (2) Load successfully. (2) Loading successfully. (3) Hold the device upright. (4) After loading, never exhale through the (4) After loading, never exhale through the mouthpiece. mouthpiece. (5) Exhale to RV before (5) Exhale to RV before (6) Place the mouthpiece into the mouth, (6) Place the mouthpiece into the mouth, sealing the lips. sealing the lips. (7) Inhale forcefully. (7) Inhale forcefully. (8) Inhale by mouth and not by nose. (8) Inhale by mouth and not by nose. (9) Continue to inhale for as long as possible. (9) Continue to inhale for as long as possible. (10) Hold breath for 4 6 s/hold breath for 8 (10) Hold breath for 4 6 s/hold breath for 8 10 s/do not hold breath. 10 s/do not hold breath. (11) Replace the mouthpiece cover. (11) Never exhale into the mouthpiece after (12) Replace the mouthpiece cover. Nelson et al 36 (1) Open the inhaler. FDA-approved (2) Push the lever. (3) Keep the inhaler level and flat (after the dose is activated). (4) Exhale (away from the mouthpiece). (5) Put the mouthpiece in your mouth. (6) Keep the inhaler level and flat (while inhaling). (7) Inhale through your mouth. (8) Inhale quickly and deeply. (9) Hold breath. (10) Exhale (away from the mouthpiece). (11) Close the inhaler. product package inserts and American College of Chest Physicians guidelines (continued) 1146 RESPIRATORY CARE JULY 2014 VOL 59 NO 7

8 Table 1. Continued Authors/Manufacturer Turbuhaler Instructions Diskus Instructions Stated Sources Nimmo et al 37 (1) Remove the mouthpiece cover. Not stated (2) Hold the device upright. (justifications given) (3) Load the dose. (4) Twist the grip back to the original position. (5) Exhale fully. (6) Place the mouthpiece between teeth and lips. (7) Breathe in through the Turbuhaler quickly and deeply. (8) Hold breath for 10 s. (9) Breath out slowly. Rönmark et al 38 (1) Release the dose (ie, hold the inhaler in the correct position). (2) Correctly releasing one dose. (3) Exhale before use. (4) Exhale away from the mouthpiece before (5) Seal lips tightly around the mouthpiece. (6) Inhale. (7) Hold breath after (9) Exhale away from the mouthpiece after Rootmensen et al 39 (1) Keep inhaler in upright position. (1) Activate the inhaler. Based on van (2) Twist the grip to the right and twist back until (2) Sit upright or stand. it clicks. (3) Breathe out to RV. (3) Place inhaler in horizontal position. (4) Tilt head back (hyperextend). (4) Sit upright or stand. (5) Close lips on inhaler. (5) Breathe out to RV. (6) Inhale forcefully and deeply. (6) Tilt head back (hyperextend). (7) Hold breath for at least 5 s. (7) Close lips on inhaler. (8) Breathe out away from the mouthpiece. (8) Inhale forcefully and deeply. (9) Hold breath for at least 5 s. (10) Breathe out away from the mouthpiece. Serra-Batlles et al 41 (1) Remove the cover. (1) Open the inhaler. Not stated (2) Keep the device upright. (2) Slide the lever. (3) Twist the grip forward. (3) Put to your mouth. (4) Twist the grip backward. (4) Breathe in the inhaler. (5) Put to mouth. (5) Close the device. (6) Breath from the inhaler. (7) Replace the cover and close the device. Manufacturers instructions, with justifications of highlighted steps (self-medication steps) given Beerendonk et al 40 and van der Palen 18 ; scoring system agreed on by 3 investigators Sestini et al 42 (1) Open the device. (1) Open the device. Manufacturers (2) Load the device. (2) Load the device. instructions (3) Keep the inhaler 45 from the vertical axis during loading. (3) Exhale away from the mouthpiece of the device after loading. (4) Exhale away from the mouthpiece of the device after loading. (4) Seal your lips around the mouthpiece during (5) Seal the lips around the mouthpiece during (5) Inhale to total lung capacity. (6) Inhale to total lung capacity. (6) Inhale by mouth and not by nose. (7) Inhale by mouth and not by nose. (7) Hold breath after (8) Exhale away from the mouthpiece of the (8) Close the device properly. device after (9) Hold breath after (10) Close the device properly. Sleath et al 43 (1) Lift off white cover to reveal the mouthpiece. (1) Open the device until it clicks. Not stated (2) Hold the device with the mouthpiece up and (2) To load a dose, hold the device horizontally twist the grip at the base back and forth one and slide the lever away from you until it time to load the dose. stops (there should be a second click). (3) Exhale gently away from the mouthpiece. (3) Hold the device horizontally and exhale gently (4) Place the mouthpiece between your lips. away from the mouthpiece. (5) Take a forceful breath in steadily and (4) Place the mouthpiece between lips. deeply. (5) Take a forceful breath in steadily and deeply. (6) Hold breath for 10 s. (7) Replace the white cover. (6) Hold breath for 10 s. (7) Close the device by sliding the thumb grip towards you until it clicks. (continued) RESPIRATORY CARE JULY 2014 VOL 59 NO

9 Table 1. Continued Authors/Manufacturer Turbuhaler Instructions Diskus Instructions Stated Sources Steier et al 44 (1) Open the cap. Not stated (2) Hold the device vertically. (3) Screw the wheel. (4) Screw the wheel back until you hear a click. (5) Exhale deeply. (6) Put the mouthpiece into your mouth. (7) Inhale deeply and strongly. (8) Hold the breath. (9) Close the cap. van Beerendonk et al 40 (1) Prepare the inhaler before usage. Netherlands Asthma (2) Keep inhaler horizontal. (3) Exhale to RV. (4) Place the mouthpiece between lips and teeth. (5) Inhale forcefully and deeply. (6) Take inhaler out of your mouth. (7) Hold breath for 5 s. (8) Exhale and repeat from step 3. Foundation van der Palen et al 18 (1) Remove the cap from the inhaler. (1) Open the inhaler. Netherlands Asthma (2) Keep the inhaler upright. (2) Push the lever back completely. Foundation (3) Rotate the grip until it clicks. (3) Exhale to RV. (4) Exhale to RV. (4) Exhale away from the mouthpiece. (5) Exhale away from the mouthpiece. (5) Place the mouthpiece between teeth and (6) Place the mouthpiece between teeth and lips. lips. (6) Inhale forcefully and deeply. (7) Inhale forcefully and deeply. (7) Hold breath for 5 s. (8) Hold breath for 5 s. (8) Exhale away from the mouthpiece. (9) Exhale away from the mouthpiece. (9) Close the inhaler. (10) Replace the cap. Steps shown in italics are those stated by the authors to be important, essential, or critical. * AstraZeneca ( ), Accessed June 6, 2014) GlaxoSmithKline ( Accessed June 6, 2014) FRC functional residual capacity RV residual volume Diskus). Some checklists also included an item for waiting a specified time between doses, 22,24,25 and one included rinsing and spitting out after use of the inhaler. 22 Some checklists (10 for the Turbuhaler and 6 for the Diskus) further identified a subset of steps as being essential or critical; these are indicated in italics in Table 1. The number of these essential steps varied, most commonly 4 for the Turbuhaler and 3 for the Diskus. For the Turbuhaler, the essential steps were usually holding the device upright during loading, twisting the base around and back to load a dose, exhaling away from the device, and inhaling strongly and forcefully. For the Diskus, the most common essential steps were opening the mouthpiece, pushing the lever to load a dose, and inhaling. However, the essential items varied substantially between checklists. In most cases, the authors stated that the selection of an item as essential or critical was based on their evaluation that if this step was incorrectly performed, little or no medication would reach the lungs. Other authors classified some steps as common problem steps. 36 van Beerendonk et al 40 divided the checklist into skilled and non-skilled items, stating that non-skilled items, such as exhaling to residual volume, required only information, whereas skilled items, such as inhaling forcefully and deeply, also required physical training. Scoring and Reporting Systems for Inhaler Technique Checklists As with checklist items, scoring systems varied greatly between publications. The most common approach was to give a score of 1 for each correctly/satisfactorily performed step and a score of 0 for each skipped or incorrectly/ unsatisfactorily performed step. 14,20,22,24,36,41,44 Kesten et al 25 graded pharmacists Turbuhaler skills as good, fair, adequate, or skipped, with a score of 0 for skipped/not adequate and a score of 1 for good/fair. Rönmark et al 38 allocated a score of 2 for correct, 1 for not completely correct, and 0 for incorrect RESPIRATORY CARE JULY 2014 VOL 59 NO 7

10 Some checklists had a more complicated scoring system. Steier et al 44 gave a total score of 0 if a step was left out that was necessary for successful inhalation (eg, opening of the cap, loading) or if the patient exhaled into the device, and all other attempts were rated from 1 9 points. Sestini et al 42 gave a score of 1 for each item of the checklist considered as minor and a score of 3 for each one considered as major. For reporting a patient s overall inhaler technique, most authors reported the inhaler technique score as the sum of the scores for each step, or as the proportion of checklist items that were performed correctly. More complicated systems were used by some authors. Rönmark et al 38 assigned overall correct use of the device if no step was performed incorrectly (score of 0) and if no more than 2 of 4 specific steps (steps 2, 3, 5, and 7 in Table 1) were not completely correct (score of 1). Lenney et al 29 provided 3 checklists for each device: the first (A, called Optimal Technique) included all steps required to use the device correctly, the second (B, called Some Delivery) included 2 3 common errors relevant to the device, and the third (C, called Little or No Delivery) included more substantial errors. Each patient s technique was graded as A, B, or C according to the checklist to which it best corresponded. For summarizing population results, the most common approaches were to report the average per-patient score and/or the proportion of patients who demonstrated all checklist steps correctly or who had any errors. 18,43,46,47 van der Palen et al 18 and Basheti et al 19,46,47 also reported the proportion of patients with correct essential technique (all essential steps in Table 1 correct), and Melani et al 33 reported the proportion of patients with any critical errors. Some authors also reported data for each individual checklist step, reporting the proportion of patients performing each step correctly 43 or incorrectly. 33 Source of Information for Checklists It was not always possible to determine the source of a published checklist (Table 1). Authors often stated that they had based their checklists on the manufacturers leaflets, 20,21,28,38,42 previously published checklists, 23,31 or national and international asthma foundation guidelines 18,22 and/or that they developed their own. Personal or expert opinion was often used to justify the checklist items; for example, Nimmo et al 37 stated that the Turbuhaler checklist steps were those identified as necessary for correct inhalation technique for the purpose of the study. Summary The above body of literature demonstrates that there is no defined standard for assessment of inhaler technique with the Turbuhaler or Diskus with regard to the number and content of steps in the relevant checklists. Not all studies stated the source of their checklists, and even when the source of the checklists was stated, there were many different sources. Scoring systems used to present the results of the assessments were very different as well, making it unfeasible to compare the results in many cases. Therefore, although overall similar processes are described in each checklist, the range of content and format presents a challenge with regard to drawing comparisons between the checklists and validation of the individual steps. A recent review has called for standardization of the way inhaler device studies are conducted and the way they are reported to physicians and health authorities. 48 Considering the above findings, there are several obvious questions at this stage. Which checklists are most appropriate to be used for future studies assessing and/or educating patients on correct Turbuhaler and/or Diskus technique? Which steps should be weighed more, that is, which steps can be considered essential steps? How should inhaler technique data be scored and reported? To answer these questions, we examined evidence for the clinical importance of each of the steps commonly included in checklists for the Turbuhaler and Diskus. Evidence for Inclusion of Individual Technique Steps in Device Checklists Each checklist deals with 3 overall processes: preparation of the device/loading of the dose, delivery of the dose, and preparation of the device for storage. Within these 3 overall processes, we identified published evidence that supports individual checklist steps. It is not possible to find evidence for some of the steps that are included in the manufacturers instructions for a particular device; these recommendations may have been developed in-house, with various options tested and some perhaps abandoned, and the evidence is not necessarily available in the public domain. Preparation of the Device. Most checklists describe the preparation of the device to include (1) removing the cover (Turbuhaler) or opening the cover (Diskus) and (2) loading a dose for delivery. (1) Although there is no published evidence on the importance, necessity, or impact of removing the cover (Turbuhaler) or opening the cover (Diskus), the design of the devices means that it would be physically impossible for any medication to be delivered if this step was not performed. This may seem so obvious as to be unnecessary to check, but a small proportion of patients fail to complete this step. 34 (2) Loading (or preparing) a dose for delivery is described for both the Turbuhaler and Diskus. For the Turbuhaler (see Fig. 1), the medication powder is stored in RESPIRATORY CARE JULY 2014 VOL 59 NO

11 bulk in a reservoir (storage unit for drug), above a dose well (dosing unit), and prior to drug administration, a single dose of power needs to be aliquoted (loaded). 49 This is achieved by holding the device upright and rotating the grip at the base of the Turbuhaler in one direction and back again. Although early Turbuhaler instructions specified starting with a counterclockwise rotation, the manufacturer later clarified that the direction of initial rotation was irrelevant provided the base was rotated in both directions, and a click was heard. If the device is upright, the drug falls by gravity from the reservoir into the dosing unit, and excess powder is scraped off to make the measured dose available. 6,50,51 This is an important step because, without it, an appropriate dose of medication will not be available for delivery. In contrast, the Diskus contains a coiled strip containing metered doses of powder (see Fig. 2). When the lever is pulled to the right, the 2 foil strips are peeled apart, and the dose is aligned with and exposed to the mouthpiece. Without the lever being pulled across, it is physically impossible for any medication to be inhaled. Delivery of the Dose. This process involves all of the breathing maneuvers required to move the drug from the device and into the body. Typically, the checklists involve a description of (1) how to exhale the air from the lungs (how much and where), (2) how to place the mouthpiece of the device into the mouth, (3) how to inhale the medication from the device, and (4) breath-holding after (1) Exhaling air prior to inhalation is a physiological process. Although some checklists do not include this step on the basis that it does not affect clinical outcomes, 52 other checklists specify exhaling to residual volume, based on clinical experience that this ensures that the patient can make a deep and forceful 19,47 For both the Turbuhaler and Diskus, it is important to exhale away from the mouthpiece, as there is evidence that exhalation into the device may reduce the dose delivered to the lung Exhalation into or near the device compromises the integrity of the powder dose: for both the Turbuhaler 12,49,51,53,56,57 and the Diskus, 58 it can displace the already loaded dose of powder and introduce moisture, potentially causing aggregation of powder particles. (2) Placing the mouthpiece between teeth and lips before inhalation (Turbuhaler and Diskus) may also influence clinical outcomes. 58 A tight seal between the lips and mouthpiece avoids air leakage, which would otherwise reduce the inspiratory flow. Placing the mouthpiece past the lips and teeth is important; otherwise, a portion of the aerosol particles may deposit onto the teeth and tongue, decreasing the amount of medication reaching the lungs. 58 (3) Inhaling forcefully and deeply (ie, generating sufficient inspiratory flow) has been shown to be important for optimal drug delivery for the Turbuhaler and Diskus, 6,29,59 as it ensures de-aggregation of the metered dose 60 and deep lung deposition. 58,61 Inspiration should be forceful from the beginning of inhalation rather than increasing gradually. 57 Failure to do so results in partial delivery of the medication to the lungs 29 and increased drug deposition in the mouth and pharynx. 57,60,62,63 Maintaining a forceful and deep inhalation from the start of the inhalation maneuver and for as long as possible ensures that most patients can use a powder inhaler (Turbuhaler and Diskus) irrespective of the resistance of the device or their disease severity. 64 However, although most patients can achieve the required flow, 65,66 flow is more likely to be a problem for the Turbuhaler than for the lower resistance Diskus. 67,68 (4) Breath-holding following inhalation (Turbuhaler and Diskus) is included in most of the published checklists and the Global Initiative for Asthma web site checklists for both the Turbuhaler and the Diskus ( org/turbohaler; Accessed June 6, 2014). This is one of the most frequently discussed items in inhaler technique checklists. 52 Although the manufacturer s instructions for the Turbuhaler do not include this step, many clinicians advise inclusion of a breath-hold for powder inhalers to avoid confusion with pressurized metered-dose inhalers, for which a breath-hold is necessary. 69 For pressurized metered-dose inhalers, the original suggestion of a 10-s breath-hold was based on lung deposition studies, 69 but the general recommendation for clinical practice is that the breath should be held only as long as is comfortable. A 5-s breath-hold is a realistic target for most patients. 70 Preparation of the Device for Storage. Replacing the cap after use of a Turbuhaler or closing the lid of the Diskus is the final step articulated in inhaler checklists. Although this step is post-drug delivery, it serves to keep the device clean, prevent foreign objects from entering the mouthpiece, and minimize absorption of moisture from the ambient environment. 58,71 Therefore these steps are important in maintaining the drug integrity for subsequent doses. For the Turbuhaler, replacing the cap is included in the manufacturer s instructions but in fewer than half of published Turbuhaler checklists. Evidence for Additional Steps There does not appear to be any published evidence to support a 30-s delay between doses, and it is not included in manufacturers instruction leaflets in countries such as Jordan, Canada, Australia, and the United States. This step would only be relevant to patients prescribed 2 or more inhalation doses on each occasion. Likewise, an instruction to rinse the mouth after taking a dose, although important for patients using inhaled corticosteroids to reduce 1150 RESPIRATORY CARE JULY 2014 VOL 59 NO 7

12 Table 2. Recommended Checklists for Assessment of Turbuhaler and Diskus Technique Checklist for Turbuhaler Technique Checklist for Diskus Technique (1) Remove the cap from the inhaler. (1) Open the inhaler. (2) Keep the inhaler upright. (2) Push the lever back completely. (3) Rotate the grip counterclockwise and then back until a click is heard. (3) Exhale to RV. (4) Exhale to RV. (4) Exhale away from the mouthpiece. (5) Exhale away from the mouthpiece. (5) Place the mouthpiece between teeth and lips. (6) Place the mouthpiece between teeth and lips. (6) Inhale forcefully and deeply. (7) Inhale forcefully and deeply. (7) Hold breath for 5 s. (8) Hold breath for 5 s. (8) Exhale away from the mouthpiece. (9) Exhale away from the mouthpiece.* (9) Close the inhaler. Essential steps (ie, if not performed correctly by the patients, little or no medication would reach the lungs) are shown in italics. * The patient should also, of course, replace the Turbuhaler cap after use. These published checklists were standardized to 9 items each to allow comparison of scores between the two devices. RV residual volume the risk of oropharyngeal side effects, is not relevant to those using the Turbuhaler or Diskus for delivery of shortor long-acting 2 agonists. Nevertheless, if the perspective of Appel 13 is adopted, that is, the better the inhaler technique (the more correct steps performed) by the patient, the better the clinical response expected, 14,47 these additional steps should be considered while delivering a complete Turbuhaler and Diskus technique education. Patients for whom a second dose or mouth rinsing is relevant may need to be asked about these steps, as they may not think to perform them when asked to demonstrate their technique. Essential Steps for the Turbuhaler and Diskus As mentioned previously, in some published checklists, a series of steps have been identified as essential. Considering the evidence above, it becomes clear that, without the completion of certain steps, it is unlikely that any medication will be delivered to the airways. It is these steps that could be considered essential. They include opening/removing the cover; loading the device, 49 which, in the case of the Turbuhaler, should be completed while holding the device upright 18,50 ; and inhaling through the mouthpiece forcefully and deeply. 57,62 Failure to perform these steps will result in no medication being available because of the physical barrier of the cap or lid, the unavailability of the drug, or the drug failing to be transported out of the inhaler. From the literature, the published checklists for the Turbuhaler and Diskus that best describe all of the steps recommended are those published by van der Palen et al 18 and Basheti et al 14 (Table 2). Reporting Turbuhaler/Diskus Technique Data To allow comparison of data from different studies, we recommend that inhaler technique data should be presented as (1) the proportion of patients with correct technique (all steps in the checklist correct); (2) the proportion of patients with correct essential technique (all essential steps identified in each checklist correct); (3) the mean SD of inhaler technique scores; and (4) for more detailed studies, the proportion of patients with correct technique for each individual step in the technique checklist. If all of these metrics are reported (or at least recommendations 1 3), appropriate comparison of populations will be possible in different locations and over time. In addition, the effectiveness of interventions designed to improve inhaler technique and thus clinical outcomes could be established. Clinical Impact of Using Inhaler Technique Checklists In the literature and in clinical practice, there is broad acceptance that poor inhaler technique is a substantial contributor to poor asthma control and to increased health care costs. 49 For pressurized metered-dose inhalers, Giraud et al 72 showed a strong relationship between poor technique, assessed with a standardized checklist, and a composite asthma instability index. A subsequent study by the same authors 15 showed that assessment and correction of inhaler technique using a standardized checklist led to a significant improvement in asthma control, particularly in patients whose inhaler technique was suboptimal at the start. 15 Although there have been many studies evaluating powder inhaler technique, a review by Lavorini et al 56 found that few studies had documented the relationship between incorrect technique and clinical outcomes; however, there is no reason to suppose that this would be any different than for pressurized metered-dose inhalers. The concept of essential steps is supported by the finding of Melani et al 33 that patients with one or more critical errors on the Turbuhaler or Diskus checklist had significantly RESPIRATORY CARE JULY 2014 VOL 59 NO

13 worse asthma control, impaired quality of life, activity limitation, and sleep disturbance. The strongest confirmation of the value of inhaler checklists comes from studies in which inhaler assessment and skills training were associated with significantly improved asthma outcomes. 14 Again, there are few studies, but in young children, Goren et al 73 showed that improved Turbuhaler technique with a rudimentary child-specific checklist was associated with greater bronchodilator effect. In the 6-month study by Basheti et al, 14 a brief pharmacy intervention, with assessment and correction of inhaler technique and checklistbased inhaler labels, led to significant improvement in asthma outcomes compared with a control group. In that study, changes in asthma control measures over time seemed to relate more to the proportion of patients with all steps correct than to average inhaler technique scores. 14,47 Considering the difference in steps between Turbuhaler and Diskus checklists, another important practical recommendation that this review can add is that, where possible, only one type of inhaler device should be used per patient. Previous studies have shown that use of different devices predisposes patients to inhaler misuse compared with using only one type of inhaler. 12,74,75 In addition, substituting a different powder inhaler for that previously used by the patient can cause confusion for the patient. 76 Skilled health care professionals have an essential role in evaluating patients inhalation technique and ensuring they are using the inhalers properly. 12,57,68 Avoiding multiple inhaler devices for a patient can also lead to fewer steps to teach/learn and hence less confusion in demonstrating/performing the individual steps per inhaler device for health care professionals and patients. Conclusions Inhaler technique checklists have been used in the majority of studies investigating the inhaler technique performance of patients and of health care professionals such as pharmacists. This literature review demonstrated considerable heterogeneity in inhaler technique checklists for the same powder devices in different studies, which makes direct comparison of results difficult. This may cause confusion for both patients and health care professionals and ultimately contribute to poor technique. The issue of inhaler technique checklist heterogeneity was first raised more than a decade ago, 16 but more work clearly needs to be done to ensure standardization of checklists for clinical and research contexts. Checklists are feasible for use in clinical research and clinical practice, with no equipment costs and with minimal time required. Unlike existing inhaler technique assessment devices, which are able to check only some components of inhaler use, use of a checklist ensures that every step required for delivery of medication is assessed. However, the differences between the various checklists and scoring systems in the literature make the direct comparison of results difficult and at times inappropriate. Hence, in this review, we have recommended checklists and scoring systems for the most commonly used powder inhalers, the Turbuhaler and Diskus, based on the literature and previous findings. If future studies in this area use common checklists and scoring systems, the problem of inhaler technique assessment heterogeneity between different studies will be resolved, allowing for more accurate comparisons between the results. From the literature, the published checklists for the Turbuhaler and Diskus that best describe all of the steps recommended above are those published by van der Palen et al 18 and Basheti et al. 14 The validity of these checklists is supported by evidence for significant improvement in asthma outcomes when technique is assessed and improved. 14 It is recommended that future studies use these checklists so that direct comparison between studies can assess the efficacy of specific interventions. REFERENCES 1. Kemp JP, Hill MR, Vaughan LM, Meltzer EO, Welch MJ, Ostrom NK. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler. Ann Allergy Asthma Immunol 1997;79(4): Richter K. Successful use of DPI systems in asthmatic patients key parameters. Respir Med 2004;98(Suppl B):S22-S Atkins PJ. Dry powder inhalers: an overview. Respir Care 2005; 50(10): Roche N, Huchon GJ. Rationale for the choice of an aerosol delivery system. J Aerosol Med 2000;13(4): Muller V, Gálffy G, Eszes N, Losonczy G, Bizzi A, Nicolini G, et al. Asthma control in patients receiving inhaled corticosteroid and longacting beta 2 -agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med 2011;11: Wetterlin K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm Res 1988;5(8): Chrystyn H. The Diskus inhaler: A review of its pharmaceutical and clinical performance. Clin Drug Invest 1999;18(4): Engel T, Heinig JH, Madsen F, Nikander K. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur Respir J 1990;3(9): Hawksworth GM, James L, Chrystyn H. Characterization of the inspiratory manoeuvre when asthmatics inhale through a Turbohaler pre- and post-counselling in a community pharmacy. Respir Med 2000;94(5): Lavorini F, Levy ML, Corrigan C, Crompton G, ADMIT Working Group. The ADMIT series issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir J 2010;19(4): Kamin WE, Genz T, Roeder S, Scheuch G, Cloes R, Juenemann R, Trammer T. The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient. J Aerosol Med 2003;16(1): Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008;102(12): RESPIRATORY CARE JULY 2014 VOL 59 NO 7

Metered Dose Inhaler (MDI)

Metered Dose Inhaler (MDI) Metered Dose Inhaler (MDI) If the inhaler has not been used before, a test dose should be fired into the air to prime the system. 1. Remove cap. 2. Shake well. 3. Breathe out fully. 4. Holding inhaler

More information

Long-term maintenance of pharmacists' inhaler technique with a novel educational tool

Long-term maintenance of pharmacists' inhaler technique with a novel educational tool Long-term maintenance of pharmacists' inhaler technique with a novel educational tool IA Basheti, HK Reddel, CL Armour, SZ Bosnic-Anticevich Dry Powder Inhalers Efficient devices, however, incorrectly

More information

Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals

Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Pocket Guide to Inhaler Technique A Step-By-Step Guide for Healthcare Professionals Endorsed by NHSGGC Respiratory Managed Clinical Network; June 2016 Designed by Medical Illustration Services Contents

More information

Appendix E: Device Technique

Appendix E: Device Technique Adult Asthma Care Guidelines for Nurses: Promoting Control of Asthma Appendix E: Device Technique Medications: Inhalation Devices Adapted with permission from The Lung Association: www.lung.ca/asthma/manage/devices.html

More information

Appendix M: Device Technique

Appendix M: Device Technique Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Appendix M: Device Technique Medications: Inhalation Devices Medications come in many forms.

More information

Inhaler technique reminder cards

Inhaler technique reminder cards Inhaler technique reminder cards Produced by the Medicines Optimisation Team NHS NEW Devon CCG For further information visit: www.newdevonccg.nhs.uk/information-for-patients/medicines-and-treatments/100073

More information

Breezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler

Breezhaler. Open to see clear capsule. How do I use my Breezhaler? Care of my Breezhaler Breezhaler 3 Pull cap off Press buttons once and release Breathe in rapidly and steadily. Hold. Open. Place capsule in chamber. Close (click). Breathe out 4 Open to see clear capsule. If not all clear

More information

Inhaler Devices. Ask the patient/carer to demonstrate the technique and correct accordingly at every opportunity.

Inhaler Devices. Ask the patient/carer to demonstrate the technique and correct accordingly at every opportunity. Inhaler Devices The most effective way of taking most asthma medicines is to inhale them so they get straight into the lungs. The best inhaler device is one that the patient can and will use. The correct

More information

Checklists for dry powder inhaler technique: a review and recommendations. Faculty of Pharmacy, University of Applied Sciences, Amman, Jordan

Checklists for dry powder inhaler technique: a review and recommendations. Faculty of Pharmacy, University of Applied Sciences, Amman, Jordan Checklists for dry powder inhaler technique: a review and recommendations Iman A Basheti, PhD Associate Professor in Clinical Pharmacy Faculty of Pharmacy, University of Applied Sciences, Amman, Jordan

More information

How to Use Inhaled Medications for Asthma and COPD

How to Use Inhaled Medications for Asthma and COPD How to Use Inhaled Medications for Asthma and COPD This information is not intended to diagnose health problems or to take the place of medical advice or care you receive from your physician or other health

More information

How can I benefit most from my COPD medications?

How can I benefit most from my COPD medications? Fact Sheet: COPD Medications and Delivery Devices How can I benefit most from my COPD medications? COPD medications can improve your symptoms. By taking the right medication at the right time, you can

More information

Your Inhaler Devices & You

Your Inhaler Devices & You 1 Your Inhaler Devices & You COUNSEL ON THE APPROPRIATE USE OF A: METERED DOSE INHALER (MDI) DRY POWDER INHALER (DPI) DISCUSS THE APPROPRIATE USAGE OF A PEAK FLOW METER AND SPACER/HOLDING CHAMBER DEVICE

More information

Respiratory Care 2. Clinical Skills School of Medicine 2015/16

Respiratory Care 2. Clinical Skills School of Medicine 2015/16 Respiratory Care 2 Clinical Skills School of Medicine 2015/16 Learning Objectives Identify the different types of inhalers and demonstrate the correct inhaler techniques for the different inhalers. Demonstrate

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate) BREEZHALER Please date initial after you have directly observed

More information

Correct Use of Inhaler Devices

Correct Use of Inhaler Devices PL Detail-Document #300206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Correct Use of

More information

NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group

NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group Inhaler technique and respiratory conditions Guidance Sheet 16 When diagnosed

More information

2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus

2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus 2008 IPAC-RS Conference Doing the Right Thing Science, Quality and Patient Focus Patient Perspective Alpha-1 1 Foundation John W. Walsh Patient Focus Personal perspective Challenges and lessons Importance

More information

GMMMG Asthma Formulary Inhaler Options August 2017

GMMMG Asthma Formulary Inhaler Options August 2017 Regular Preventer Beclometasone Beclometasone Beclometasone Brand name Qvar Easi-Breathe Clenil Modulite Easyhaler Device MDI MDI DPI Strengths 50 microgram 100 microgram 200 microgram Adult asthma 2 inhalations

More information

Skills Checklist Manual

Skills Checklist Manual Skills Checklist Manual Alexandra L. Quittner, Ph.D. Kristen K. Marciel, Ph.D. Ivette Cruz, M.S. University of Miami Quittner, Marciel, & Cruz, 2009 i revised 2/5/09 Table of Contents Instructions 1 Airway

More information

Using an Inhaler and Nebulizer

Using an Inhaler and Nebulizer Using an Inhaler and Nebulizer Introduction An inhaler is a handheld device that is used to deliver medication directly to your airways. A nebulizer is an electric or battery powered machine that turns

More information

Patient. Device Clinician. Safety & efficacy

Patient. Device Clinician. Safety & efficacy Patient Device Clinician Formulation Safety & efficacy 1. Modified from Daley-Yates et al., Expert Opin. Drug Deliv. 2011: 8(10):1297-1308 2. Modified from Laube et al., Eur Respir J 2011; 37: 1308 1331

More information

OXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation

OXEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION OEZE TURBUHALER formoterol fumarate dihydrate dry powder for oral inhalation This leaflet is part III of a three-part Product Monograph published when

More information

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation PATIENT INFORMATION ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is ADVAIR DISKUS? ADVAIR DISKUS combines the inhaled corticosteroid

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If

More information

The Medical Letter. on Drugs and Therapeutics

The Medical Letter. on Drugs and Therapeutics The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:

More information

My Asthma Log. Tommy Traffic Light. NHS Number: Name:

My Asthma Log. Tommy Traffic Light. NHS Number: Name: My Asthma Log Tommy Traffic Light NHS Number: Name: My Asthma Log Book This book is designed to help you understand and learn about managing your asthma. You should take your book with you to all your

More information

Anoro Ellipta Patient Handout

Anoro Ellipta Patient Handout Anoro Ellipta Patient Handout 1. OPEN Slide the cover down to expose the mouthpiece. You should hear a click. The counter will count down by 1 number. Do not shake this kind of inhaler. Note: If you open

More information

How to Use Inhaled Medications

How to Use Inhaled Medications How to Use Inhaled Medications FOR ASTHMA AND COPD introduction Inhaled medications are an important part of controlling and treating asthma and chronic obstructive pulmonary disease (COPD). The medication

More information

COPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD

COPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD COPD RESOURCE PACK Section 5 Drug Treatment & Inhalers in Stable COPD In this section: 1. Links to Fife Formulary 2. Pharmacological Management of Stable COPD 3. How to use a Metered Dose Inhaler 4. How

More information

INSTRUCTIONS FOR USE. INBRIJA (in-brih-jah) (levodopa inhalation powder) For Oral Inhalation Only

INSTRUCTIONS FOR USE. INBRIJA (in-brih-jah) (levodopa inhalation powder) For Oral Inhalation Only INSTRUCTIONS FOR USE INBRIJA (in-brih-jah) (levodopa inhalation powder) For Oral Inhalation Only Read and follow these instructions before you start using INBRIJA and each time you get a refill. There

More information

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop INHALERS for COPD Dr Christopher Worsnop Department of Respiratory Medicine Austin Hospital INTRODUCTION Most drugs for COPD are given via inhalers. This reduces the dose that needs to be given and delivers

More information

OXEZE TURBUHALER formoterol fumarate dihydrate

OXEZE TURBUHALER formoterol fumarate dihydrate IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION OEZE TURBUHALER formoterol fumarate dihydrate This leaflet is part III of a three-part Product Monograph published when OEZE TURBUHALER was approved

More information

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate Package leaflet: Information for the user Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate PACKAGE LEAFLET: INFORMATION FOR THE USER Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need

More information

I. Subject: Medication Delivery by Metered Dose Inhaler (MDI)

I. Subject: Medication Delivery by Metered Dose Inhaler (MDI) I. Subject: Medication Delivery by Metered Dose Inhaler (MDI) II. Policy: Aerosol medication administration by metered dose inhaler will be performed upon a physician's order by Respiratory Therapy personnel.

More information

CARE AT HOME: ASTHMA. A guide for parents. childrensmn.org

CARE AT HOME: ASTHMA. A guide for parents. childrensmn.org CARE AT HOME: ASTHMA A guide for parents childrensmn.org Content Your child has asthma a chronic lung disease. To best control the symptoms of asthma, it is important that you learn all you can about asthma.

More information

What You Need to Know about Metered-Dose Inhalers and the HFA Propellant

What You Need to Know about Metered-Dose Inhalers and the HFA Propellant What You Need to Know about Metered- Inhalers and the HFA Propellant There are a number ways to deliver inhaled medication. They include: Metered-dose inhaler () Metered-dose inhaler with spacer/holding

More information

Inhaler Standards and Competency Document

Inhaler Standards and Competency Document Inhaler Standards and Competency Document Inhaler Standards and Competency Document Authors: Jane Scullion Respiratory Nurse Consultant University Hospitals of Leicester NHS Trust Monica Fletcher CEO of

More information

GMMMG COPD Formulary Inhaler Options October 2017

GMMMG COPD Formulary Inhaler Options October 2017 BNF 3.1.1 Adrenocepter agonists (SABA) Salbutamol Salbutamol Terbutaline Brand name Airsalb Ventolin Evohaler Bricanyl Turbohaler Device MDI MDI Dry powder Strengths 100 microgram 100 microgram 500 microgram

More information

Information for those treated with DuoResp Spiromax

Information for those treated with DuoResp Spiromax Respiratory Engelska Information for those treated with DuoResp Spiromax Why have I been prescribed DuoResp Spiromax? DuoResp Spiromax is a medicine used in the treatment of asthma and chronic obstructive

More information

COPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD?

COPD Device Workshop. Summary. Role of inhaler device in COPD. Why use inhaler device in COPD? Part 1 Role of inhaler device in COPD COPD Device Workshop Dr Philip Lee Respiratory and Sleep Physician St George Hospital, Sydney Part 2 Part 3 Part 4 Incorrect inhaler technique-adverse clinical outcomes

More information

Medications. prescribed. Use as. A s t h m a B a s i c s # 3

Medications. prescribed. Use as. A s t h m a B a s i c s # 3 Medications A s t h m a B a s i c s # 3 Use as prescribed The Asthma Basics Booklet Series was developed to provide Canadians with asthma, current and accurate information about asthma management. This

More information

Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA?

Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA? Patient Information ARNUITY ELLIPTA (ar-new-i-te e-lip-ta) (fluticasone furoate inhalation powder) for oral inhalation use What is ARNUITY ELLIPTA? ARNUITY ELLIPTA is an inhaled corticosteroid (ICS) medicine

More information

NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS

NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS NEBULIZERS, METERED DOSE INHALERS, AND DRY POWDER INHALERS Douglas S. Gardenhire, Ed.D, RRT-NPS MODULE 1 Manipulate Small Volume Nebulizers by Order or Protocol 1 Objectives for Module 1 At the end of

More information

Understanding Your Inhaler

Understanding Your Inhaler Understanding Your Inhaler Contents You and your inhaler...1 Asthma Medicines...2 Preventers...2 Relievers...2 Symptom controllers...2 Combinations...2 Different kinds of asthma inhalers...3 Metered dose

More information

MEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol

MEDICATION GUIDE. ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol MEDICATION GUIDE ADVAIR [ad vair] HFA 45/21 (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol ADVAIR HFA 115/21 (fluticasone propionate 115 mcg and salmeterol 21 mcg) Inhalation

More information

Diverse Inhaler Devices: A Big Challenge for Health-Care Professionals

Diverse Inhaler Devices: A Big Challenge for Health-Care Professionals Diverse Inhaler Devices: A Big Challenge for Health-Care Professionals Abdullah Alismail MSc RRT-NPS RRT-SDS, Cassaundra A Song MHID, Michael H Terry RRT, Noha Daher DrPH, Waleed A Almutairi RRT-NPS, and

More information

Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a

Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a 1 2 Q. What are metered-dose inhalers? A. These are devices that dispense medicines directly into the lungs, in the form of a mist or aerosol in a specific dosage. In an MDI, the medicine is suspended

More information

Instructions for Use ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol

Instructions for Use ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol Instructions for Use ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol Read this Instructions for Use for ALVESCO Inhalation Aerosol before you start using it and each time you get a refill. There

More information

Asthma. If an Ambulance is required - call immediately - do not delay. H & A Training PL RTO No:90871

Asthma. If an Ambulance is required - call immediately - do not delay. H & A Training PL RTO No:90871 Asthma is a reversible breathing problem caused from sudden or progressive narrowing and spasming of the smaller airways and includes mucus production, which interferes with oxygen exchange. People who

More information

Effect of simulation in training pharmacy students on correct inhaler technique. Iman Basheti

Effect of simulation in training pharmacy students on correct inhaler technique. Iman Basheti Effect of simulation in training pharmacy students on correct inhaler technique Iman Basheti Iman Basheti: University of Applied Sciences, Shafa Badran, Amman, Jordan. Email: dr_iman@asu.edu.jo Abstract

More information

What you need to know about inhalers and how to use them Henry Chrystyn PhD, FRPharmS and David Price MA, MRCGP, DRCOG

What you need to know about inhalers and how to use them Henry Chrystyn PhD, FRPharmS and David Price MA, MRCGP, DRCOG What you need to know about inhalers and how to use them Henry Chrystyn PhD, FRPharmS and David Price MA, MRCGP, DRCOG VM The authors describe the problems that arise with metered-dose and dry-powder inhalers,

More information

Patient adherence to inhaled therapy A clinical perspective. Nicolas Roche Cochin, Site Val de Grâce University Paris Descartes, Paris, France

Patient adherence to inhaled therapy A clinical perspective. Nicolas Roche Cochin, Site Val de Grâce University Paris Descartes, Paris, France Patient adherence to inhaled therapy A clinical perspective Nicolas Roche Cochin, Site Val de Grâce University Paris Descartes, Paris, France 1 Disclosures Aerocrine Almirall AstraZeneca Boehringer Ingelheim

More information

Wijdan H Ramadan 1 and Aline T Sarkis 2. Introduction. Original paper

Wijdan H Ramadan 1 and Aline T Sarkis 2. Introduction. Original paper Original paper Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative

More information

Medications. prescribed. Use as. Your Asthma Basics series: Asthma Basics #3. Diagnosis Triggers Medications Kids

Medications. prescribed. Use as. Your Asthma Basics series: Asthma Basics #3. Diagnosis Triggers Medications Kids Medications Asthma Basics #3 Your Asthma Basics series: 1 2 3 Diagnosis Triggers Medications Kids Use as prescribed Supported by unrestricted educational grants from: For more information from the Asthma

More information

Inhaler Technique Training and Health-Care Professionals: Effective Long-Term Solution for a Current Problem

Inhaler Technique Training and Health-Care Professionals: Effective Long-Term Solution for a Current Problem Inhaler Technique Training and Health-Care Professionals: Effective Long-Term Solution for a Current Problem Iman A Basheti PhD, Eyad A Qunaibi PhD, Salim A Hamadi PhD, and Helen K Reddel PhD INTRODUCTION:

More information

Advanced Inhaler Technique. Learning Outcomes. Disclosure 1.1. Belgian Chocolate, French Champagne and Inhaled Medication: Too Good To Waste?

Advanced Inhaler Technique. Learning Outcomes. Disclosure 1.1. Belgian Chocolate, French Champagne and Inhaled Medication: Too Good To Waste? Advanced Inhaler Technique Learning Outcomes Describe the mechanism of different inhalers Explain how inspiratory flow can effect drug delivery for different inhalers Counsel a patient on the correct use

More information

PATIENT INFORMATION RELENZA

PATIENT INFORMATION RELENZA PATIENT INFORMATION RELENZA (ruh-lens-uh) (zanamivir inhalation powder) for oral inhalation use What is RELENZA? RELENZA is a prescription medicine used to: treat the flu (influenza A and B virus) in people

More information

Package Leaflet: Information for the user. RELENZA 5 mg per dose, inhalation powder, pre-dispensed zanamivir

Package Leaflet: Information for the user. RELENZA 5 mg per dose, inhalation powder, pre-dispensed zanamivir Package Leaflet: Information for the user RELENZA 5 mg per dose, inhalation powder, pre-dispensed zanamivir Read all of this leaflet carefully before you start using this medicine because it contains important

More information

The problem with critical and non-critical inhaler errors

The problem with critical and non-critical inhaler errors The problem with critical and non-critical inhaler errors Federico Lavorini MD, PhD Dept. Experimental and Clinical Medicine Careggi University Hospital Florence, Italy Presenter disclosures Federico Lavorini

More information

Health Professional Manual

Health Professional Manual Health Professional Manual Session 4 COPD Medication and appropriate use of Inhaler Devices COPD medication Inhaler devices Metered dose inhaler (MDI) MDI with a spacing device Accuhaler Handihaler Turbohaler

More information

Counseling About Turbuhaler Technique: Needs Assessment and Effective Strategies for Community Pharmacists

Counseling About Turbuhaler Technique: Needs Assessment and Effective Strategies for Community Pharmacists Counseling About Turbuhaler Technique: Needs Assessment and Effective Strategies for Community Pharmacists Iman A Basheti BPharm Sci, Helen K Reddel MBBS PhD FRACP, Carol L Armour BPharm (Hons) PhD, and

More information

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines

More information

MEDICATION GUIDE ANORO ELLIPTA

MEDICATION GUIDE ANORO ELLIPTA MEDICATION GUIDE ANORO ELLIPTA [a-nor oh e-lip-ta] (umeclidinium and vilanterol inhalation powder) for oral inhalation What is the most important information I should know about ANORO ELLIPTA? ANORO ELLIPTA

More information

Combination DPI DEVICES TECHNIQUES,PRIMING & CARE

Combination DPI DEVICES TECHNIQUES,PRIMING & CARE Combination DPI DEVICES TECHNIQUES,PRIMING & CARE Lisa Romard, MS, RN, CPNP, ANP, AE- C Disclosures: This presentation and clinical recommendations support best available evidence from medical literature.

More information

PATIENT INFORMATION FORM

PATIENT INFORMATION FORM PATIENT INFORMATION FORM "I am going to ask you a number of questions about your asthma. The set of questions is somewhat long, but I will try to move through it fairly quickly so that we can complete

More information

Do not use Easyhaler Salbutamol if you are allergic (hypersensitive) to: Salbutamol lactose

Do not use Easyhaler Salbutamol if you are allergic (hypersensitive) to: Salbutamol lactose Package leaflet: Information for the patient user Easyhaler Salbutamol Sulphate 100 and 200 micrograms/dose inhalation powder Salbutamol sulphate (salbutamol) Read all of this leaflet carefully before

More information

INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET

INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET INHALATION TECHNIQUES FOR CHILDREN AND Adolescents Oslo University Hospital, RIKSHOSPITALET DIVISION OF PAEDIATRIC AND ADOLESCENT MEDICINE (BARNEKLINIKKEN) VOKSENTOPPEN The information contained in this

More information

ADASUVE (LOXAPINE) INHALATION POWDER. EDUCATION PROGRAM for HEALTHCARE PROFESSIONALS

ADASUVE (LOXAPINE) INHALATION POWDER. EDUCATION PROGRAM for HEALTHCARE PROFESSIONALS ADASUVE (LOXAPINE) INHALATION POWDER EDUCATION PROGRAM for HEALTHCARE PROFESSIONALS August2017 December 2012 PMR-JUN-2017-0017 ADASUVE Risk Evaluation and Mitigation Strategy (REMS) Education Program Content

More information

GlaxoSmithKline. Renal impairment. Hepatic impairment

GlaxoSmithKline. Renal impairment. Hepatic impairment RELENZA GlaxoSmithKline Zanamivir QUALITATIVE AND QUANTITATIVE COMPOSITION Each RELENZA ROTADISK consists of four regularly spaced double foil blisters each containing a white to off-white micronised powder

More information

Understanding COPD Medications

Understanding COPD Medications Understanding COPD Medications University of Illinois College of Pharmacy November 15, 2018 Objectives Describe tools to help with medication adherence Develop a plan to prevent and manage worsening COPD

More information

Inhaler technique for people with asthma or COPD

Inhaler technique for people with asthma or COPD INFORMATION PAPER INHALER FOR HEALTH TECHNIQUE PROFESSIONALS FOR PEOPLE WITH ASTHMA OR COPD INHALER TECHNIQUE FOR PEOPLE WITH ASTHMA OR COPD Inhaler technique for people with asthma or COPD UPDATED KEY

More information

MANAGEMENT OF ASTHMA SPRING Presented by:

MANAGEMENT OF ASTHMA SPRING Presented by: MEDS@Work MANAGEMENT OF ASTHMA SPRING 2013 Presented by: Lusia Fomuso PharmD candidate 2014 Olivia Sibailly PharmD candidate 2014 Kimberly Biedka PharmD candidate 2014 Dr. Donna Bartlett PharmD CGP RPh

More information

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult)

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult) Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Assisting a Service User to use an Inhaler (Adult) CLINICAL GUIDELINES ID TAG Medicines Management Specific Title: Procedure: Assisting

More information

PATIENT INFORMATION BREO ELLIPTA

PATIENT INFORMATION BREO ELLIPTA PATIENT INFORMATION BREO ELLIPTA [BRE-oh e-lip-ta] (fluticasone furoate and vilanterol inhalation powder) for oral inhalation What is BREO ELLIPTA? BREO ELLIPTA combines an inhaled corticosteroid (ICS)

More information

Inhaled Corticosteroids for the Treatment of Chronic Asthma in Adults & Adolescents aged 12 years & over

Inhaled Corticosteroids for the Treatment of Chronic Asthma in Adults & Adolescents aged 12 years & over Manufacturer Submission To The National Institute for Health and Clinical Excellence By GlaxoSmithKline UK Inhaled Corticosteroids for the Treatment of Chronic Asthma in Adults & Adolescents aged 12 years

More information

1 What Flixotide is and what it is used for

1 What Flixotide is and what it is used for GSK Logo Package Leaflet: Information for the user Flixotide Diskus 50 micrograms, 100 micrograms, 250 micrograms, 500 micrograms Inhalation Powder, pre-dispensed (fluticasone propionate) Read all of this

More information

Student Paper PHARMACY PRACTICE. Keywords: asthma, inhalers, patient education

Student Paper PHARMACY PRACTICE. Keywords: asthma, inhalers, patient education Assessment of Asthma Inhaler Technique in Two Community Pharmacies Nicole Farabaugh, PharmD Candidate; Ashlee McMillan, PharmD, BCACP; and Gretchen Garofoli, PharmD, BCACP WVU School of Pharmacy Keywords:

More information

Serevent Diskus 50 microgram per metered dose inhalation powder, pre-dispensed

Serevent Diskus 50 microgram per metered dose inhalation powder, pre-dispensed Agency Approval Date: Not applicable as IA Text Date: 27 April 2015 CO-0111149 GSK Logo Package Leaflet: Information for the User Serevent Diskus 50 microgram per metered dose inhalation powder, pre-dispensed

More information

EduCare Knowledge & Skill Assessment Medication I Routes

EduCare Knowledge & Skill Assessment Medication I Routes EduCare Knowledge & Skill Assessment Medication I Routes Employee Name Date Demonstration/Skill Assessment Oral (O) Pass Fail 1. Wash your hands; apply gloves. 2. Perform the 3 safety checks on the Simple

More information

Aerosol Delivery Devices

Aerosol Delivery Devices Aerosol Delivery Devices Judy Bielenda LRRT Respiratory Therapy Clinical Specialist Pediatric Asthma Education Coordinator University of Michigan C.S. Mott Children s and Von Voigtlander Women s Hospital

More information

Prime Asthma Relief Refill NDC

Prime Asthma Relief Refill NDC Prime Asthma Relief Refill NDC15343-104-40 Epinephrine Inhalation Bronchodilator, OTC DrNaturalHealing, Inc. 111 McCoy Street Milford, DE 19963 USA 1 EPINEPHRINE INHALATION FOR ORAL INHALATION ONLY ACTIVE

More information

RightBreathe to help with inhaler prescribing and technique

RightBreathe to help with inhaler prescribing and technique www.rightbreathe.com RightBreathe to help with inhaler prescribing and technique Dr Azhar Saleem GP Respiratory Lead, Lambeth CCG GP Specialist NHS London Procurement Partnership Clinical Lead RightBreathe

More information

PATIENT INFORMATION INCRUSE ELLIPTA

PATIENT INFORMATION INCRUSE ELLIPTA PATIENT INFORMATION INCRUSE ELLIPTA [IN-cruise e-lip-ta] (umeclidinium inhalation powder) for oral inhalation What is INCRUSE ELLIPTA? INCRUSE ELLIPTA is an anticholinergic medicine. Anticholinergic medicines

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Symbicort Turbohaler 400/12, inhalation powder budesonide, formoterol fumarate dihydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER Symbicort Turbohaler 400/12, inhalation powder budesonide, formoterol fumarate dihydrate PACKAGE LEAFLET: INFORMATION FOR THE USER Symbicort Turbohaler 400/12, inhalation powder budesonide, formoterol fumarate dihydrate Read all of this leaflet carefully before you start taking this medicine.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER FORMAXA AXAHALER 12 micrograms/dose, inhalation powder, hard capsule (formoterol fumarate) Read all of this leaflet carefully before you start using this medicine.

More information

Practical Problems With Aerosol Therapy in COPD. Joseph L Rau PhD RRT FAARC

Practical Problems With Aerosol Therapy in COPD. Joseph L Rau PhD RRT FAARC Special Articles Practical Problems With Aerosol Therapy in COPD Joseph L Rau PhD RRT FAARC Introduction Problems With Use of MDIs Synchronizing Inhalation With MDI Actuation Lack of a Dose Counter Medical

More information

A multitude of devices

A multitude of devices A multitude of devices Dr Andrew Scroop Respiratory Consultants 15 th September 2018 STEPWISE PHARMACOLOGICAL MANAGEMENT OF STABLE COPD COPD Inhalers MILD FEV 1 60 80% predicted few symptoms breathless

More information

Concurrent Use Of Metered Dose Inhalers Without Spacer And Dry Powder Inhalers By Asthmatic Children Adversely Affect Proper Inhalation Technique

Concurrent Use Of Metered Dose Inhalers Without Spacer And Dry Powder Inhalers By Asthmatic Children Adversely Affect Proper Inhalation Technique ISPUB.COM The Internet Journal of Pediatrics and Neonatology Volume 13 Number 1 Concurrent Use Of Metered Dose Inhalers Without Spacer And Dry Powder Inhalers By Asthmatic Children Adversely Affect Proper

More information

your breathing problems worsen quickly. you use your rescue inhaler, but it does not relieve your breathing problems.

your breathing problems worsen quickly. you use your rescue inhaler, but it does not relieve your breathing problems. MEDICATION GUIDE ADVAIR DISKUS [ad vair disk us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is the most important information I should know about ADVAIR DISKUS?

More information

DULERA [dew-lair-ah] 100 mcg/5 mcg DULERA 200 mcg/5 mcg What is DULERA? DULERA is not used to relieve sudden breathing problems Do not use DULERA:

DULERA [dew-lair-ah] 100 mcg/5 mcg DULERA 200 mcg/5 mcg What is DULERA? DULERA is not used to relieve sudden breathing problems Do not use DULERA: PATIENT INFORMATION DULERA [dew-lair-ah] 100 mcg/5 mcg (mometasone furoate 100 mcg and formoterol fumarate dihydrate 5 mcg) Inhalation Aerosol DULERA 200 mcg/5 mcg (mometasone furoate 200 mcg and formoterol

More information

Pulmonary deposition of inhaled drugs

Pulmonary deposition of inhaled drugs Pulmonary deposition of inhaled drugs Federico Lavorini Dept. Experimental and Clinical Medicine Careggi University Hospital Florence - Italy Presenter Disclosures F.L. has received in the last 5 years

More information

Evaluation of Inhaler Techniques Among Asthma Patients Seen in Nigeria: An Observational Cross Sectional Study

Evaluation of Inhaler Techniques Among Asthma Patients Seen in Nigeria: An Observational Cross Sectional Study Original Article Evaluation of Inhaler Techniques Among Asthma Patients Seen in Nigeria: An Observational Cross Sectional Study Onyedum CC, Desalu OO 1, Nwosu NI 2, Chukwuka CJ 2, Ukwaja KN 3, Ezeudo C

More information

Package leaflet: Information for the user. Seretide Accuhaler

Package leaflet: Information for the user. Seretide Accuhaler Package leaflet: Information for the user Seretide Accuhaler 50 microgram /100 microgram /dose inhalation powder, pre-dispensed. 50 microgram /250 microgram /dose inhalation powder, pre-dispensed. 50 microgram

More information

Patient Guide. This information is for patients prescribed Sereflo TM inhaler

Patient Guide. This information is for patients prescribed Sereflo TM inhaler Patient Guide This information is for patients prescribed Sereflo TM inhaler Sereflo TM is used to help treat or prevent symptoms of asthma and is indicated for use in adults with asthma 18 years of age

More information

Fig 1. How to use the In-Check M. Clinically Effective Flow Rate L/Min

Fig 1. How to use the In-Check M. Clinically Effective Flow Rate L/Min Fig 1. How to use the In-Check M 1 2 3 4 5 6 Clinically Effective Flow Rate 30-60 L/Min 1 Instructions for Use Consult Instructions for Use. Introduction The In-Check M is an inhalation airflow meter that

More information